NEOPIN News
-
2024
Oct / 14 -
2024
Apr / 23- Harnessing AI to Combat Hepatitis: Virtual Screening Tool Identifies Dormant Inhibitors
- Apr 23, 2024 at 05:02 am
- A new computational methodology, HBCVTr, was developed to predict the antiviral activity of small molecules against hepatitis B virus (HBV) and hepatitis C virus (HCV) using their SMILES notations. This methodology combines bidirectional and auto-regressive transformer (BART) architecture with atom-wise and fraction-wise tokenization techniques to capture the sequential information and chemical features of SMILES. The models were trained and evaluated on curated datasets containing 1941 and 7454 compounds for HBV and HCV, respectively. The HBCVTr models achieved superior performance compared to various machine learning models and existing methods, with high accuracy and robust prediction capabilities. Virtual screening using the HBCVTr models identified potential HBV and HCV inhibitors with promising pharmacokinetic properties. Molecular docking and molecular dynamics simulations further validated the binding affinity and stability of the top candidates, providing insights into their potential mechanisms of action. This methodology offers a valuable tool for discovering and designing novel antiviral therapies against HBV and HCV.
-
- {{val.name}}
- {{val.createtime}}
- {{val.seo_description}}
Communtity feeds
-
- Twitter source
- RationalGaze Nov 23, 2024 at 04:58 pm
-
- Twitter source
- Üstad Splinter Nov 23, 2024 at 04:49 pm
-
- Twitter source
- 🔶شيماء / عملات رقمية🌺 Nov 23, 2024 at 04:48 pm
-
- Twitter source
- LEO | SOLANA Nov 23, 2024 at 04:39 pm
-
- Twitter source
- Lion Calls Official Nov 23, 2024 at 04:39 pm
-
- Twitter source
- {{val.author }} {{val.createtime }}